Handelsavisen
prelaunch
HU
HUN NYSE Diversified Chemicals

Huntsman CORP

$11,43
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
2,0B USD
P/E
EV / Rev
0,6x
Div yield
7,33 %
Op margin
-2,3 %
ROE
-10,6 %
Net margin
-5,0 %
Debt / equity
0,77
Beta
52w range
Volume
Day range
Prev close
$11,43
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

Huntsman Corporation manufactures and sells commodity and specialty chemicals, generating revenue through its global production and distribution network.

Business. Huntsman CORP (NYSE: HUN) is a diversified chemicals company operating within the Basic Materials sector. The firm generates revenue through the sale of chemical products. Headquarters and specific operating segment details are not provided in the available data. The company is primarily listed on the New York Stock Exchange under the ticker symbol HUN.

Classification99 %
SectorBasic Materials
Industry groupDiversified Chemicals
Generated · model-assisted
Sell-side consensus
HOLD14 analysts
2 buy10 hold2 sell
Avg 12m price target15,00

Analyst recommendations

14 analysts · consensus Hold
Buy2
Hold10
Sell2
12-month price target
15,00
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Hold
14 analysts · indicative
Ownership
AQR Capital Management, LLC
largest disclosed fund holder
Profitability
-10,6 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning HUN.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to HUN. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Huntsman CORP (NYSE: HUN) is a diversified chemicals company operating within the Basic Materials sector. The firm generates revenue through the sale of chemical products. Headquarters and specific operating segment details are not provided in the available data. The company is primarily listed on the New York Stock Exchange under the ticker symbol HUN.

    Classification99 %
    SectorBasic Materials
    Industry groupDiversified Chemicals
    AI synthesis
    GENERATED

    Huntsman Corporation maintains a capital structure characterized by significant leverage, with total debt of $2.06 billion against $2.68 billion in total equity, resulting in a debt-to-equity ratio of 0.77. The company holds $369 million in cash and equivalents, which is insufficient to cover total debt, leading to a negative net cash position. Liquidity is assessed as medium, supported by a current ratio of 1.27, indicating adequate short-term asset coverage for liabilities. The market capitalization stands at $1.98 billion, with a price-to-book ratio of 1.0, suggesting the market values the company at its tangible book value.

    Profitability metrics reflect a challenging operating environment, with the company reporting a net loss of $53 million and an operating loss of $16 million for the latest period. Return on equity is negative at -10.59%, and return on assets is -3.98%, indicating an inability to generate positive returns on invested capital. The gross profit of $183 million on $1.42 billion in revenue yields a gross margin of approximately 12.9%, which is pressured by input costs and competitive dynamics in the chemical sector. The negative free cash flow of $91 million, driven by an operating cash flow deficit of $53 million and $38 million in capital expenditures, highlights the strain on internal cash generation.

    Key takeaways
    • The company reports a net loss of $53 million and negative free cash flow of $91 million, indicating significant profitability challenges.
    • Debt-to-equity ratio of 0.77 and negative net cash position highlight leverage risks and the need for careful liquidity management.
    • Analyst price targets suggest a potential upside, with a mean target of $15.00 compared to the current price of $11.43.
    • Low dilution risk is a positive factor, suggesting no immediate pressure from share issuance.
    • Upcoming earnings release on July 30, 2026, will be a key event for assessing future performance and guidance.
    • Lack of historical data limits the ability to assess growth trends and long-term profitability improvements.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 4

    Huntsman generated $116 million in free cash flow during FY2024, demonstrating positive cash generation capabilities despite operating losses.

    The company reduced long-term debt to $1.51 billion in one FY2024 period, indicating active balance sheet deleveraging efforts.

    Net income surged 153.4% year-over-year in the latest FY2024 period, showing significant bottom-line improvement potential.

    Operating income increased by 436.0% year-over-year in the latest FY2024 period, highlighting strong operational leverage recovery.

    BEAR CASE · 3

    Huntsman faces high credit risk according to internal risk flags, signaling potential difficulties in meeting financial obligations.

    The company reported a net loss of $284 million in FY2024, reflecting severe profitability challenges and negative net margins.

    The net debt to EBITDA ratio stands at 10.14, indicating high leverage and limited financial flexibility.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-03-31
    Q4 2025 · Quarter highlights

    Revenue $1.42B; Operating income -$16.0M.

    Revenue$1.42B
    Operating income-$16.0M
    Net income-$53.0M
    Free cash flow-$91.0M
    EPS
    Operating cash flow-$53.0M
    Financials
    Income statement
    Revenue$1.42B
    Gross profit$183.0M
    Operating income-$16.0M
    Net income-$53.0M
    Margins
    Gross margin12.9%
    Operating margin-1.1%
    Net margin-3.7%
    FCF margin-6.4%
    Balance sheet
    Total assets$7.13B
    Total liabilities$4.23B
    Total equity$2.68B
    Cash & equivalents$369.0M
    Long-term debt$1.68B
    Cash flow
    Operating cash flow-$53.0M
    CapEx$38.0M
    Free cash flow-$91.0M
    SBC$9.0M
    P&L flow · revenue → net income
    Revenue $1.42BOperating costs $1.44BTax $37.0MNet income $53.0M
    Highlights
    • Revenue $1.42B
    • Operating income -$16.0M
    • Net margin -3.7%

    Valuation FY

    Market price
    $11,43
    Market cap
    $1.98B
    Enterprise value
    $3.66B
    P/E
    Non-GAAP P/E
    EV / Revenue
    0.6x
    EV / Op income
    EV / OCF
    12.7x
    P / B
    1.0x
    P / Tangible book
    1.0x
    Tangible book
    $1.98B
    Net cash
    -$1.69B
    Current ratio
    1.3
    Debt / equity
    0.8
    ROA
    -4.0%
    ROE
    -10.6%
    Cash conversion
    -102.0%
    CapEx / revenue
    3.0%
    SBC / revenue
    0.5%
    Dilution ratio
    -0.2%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships1 disclosed relationship · 1 type · extracted from filings & disclosures
    Partners1
    Basf SEBAS.DEPartner95%Source ↗

    Supply chain

    Vendors → HUN ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSHUNHUNHuntsman CORP1 entityBasf SECommodity & Specialty ChDE
    1 mention in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-06-24

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution16 analysts
    Strong buy1
    Buy1
    Hold10
    Sell3
    Strong sell1
    12-month price target$13,08 · Median $14,00
    Low $10,00High $16,00
    Operating income · consensus54,8M USD
    EPS surprise
    −53,0 %
    reported vs consensus · miss
    Revenue surprise
    −3,6 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$11,00
    Mean$15,00
    Median$14,00
    High$30,00
    Spot$11,43
    +31.2 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-2,3 %Bottom quartile
    Net Margin-5,0 %Bottom quartile
    ROE-10,6 %Bottom quartile
    Capex / Rev3,0 %Best in class
    D/E0,77Bottom quartile
    Cash Conv-1,02Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net disposed 213 141 sh5 exercises · 5 grants8 insiders
    • Hansen Steen WeienDivision President · Phantom Stock → Common StockDisposed 1 513exercise · 2026-02-13
    • Hansen Steen WeienDivision President · Phantom Stock → Common StockDisposed 1 950exercise · 2026-02-13
    • Hansen Steen WeienDivision President · Phantom Stock → Common StockDisposed 3 141exercise · 2026-02-13
    • Egan CynthiaDirector · Stock Units → Common StockAcquired 12 434grant · 2026-02-12
    • Sewell David BDirector · Stock Units → Common StockAcquired 12 434grant · 2026-02-12
    • Tighe Jan EDirector · Stock Units → Common StockAcquired 12 434grant · 2026-02-12
    • Ferrari DanieleDirector · Stock Units → Common StockAcquired 12 434grant · 2026-02-12
    • DULA SONIADirector · Stock Units → Common StockAcquired 12 434grant · 2026-02-12
    • Huntsman Peter RDirector, Chairman, President & CEO · Option (Right to Buy) → Common StockDisposed 241 496 @ $8,86exercise · 2026-02-03
    • Wright Scott JDivision President · Option (right to buy) → Common StockDisposed 27 211 @ $8,86exercise · 2025-12-02

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Regulatory filings
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Ev To Revenue
      enterprise_value / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Huntsman CORP company facts · 2026-07-29
    • Huntsman CORP 10-Q 2026-05-01 · 2026-07-29
    • Huntsman CORP 10-K 2026-02-18 · 2026-07-29
    • Huntsman CORP 10-Q 2025-11-07 · 2026-07-29
    • Huntsman CORP 10-Q 2025-08-01 · 2026-07-29
    • allocator_boost (allocator) on HUN · 2026-07-29
    • Huntsman Corp Market data — analyst estimates · 2026-07-29
    • Huntsman Corp Market data — ESG · 2026-07-29

    Ownership & reference

    Top holders

    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,07 %$151M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,03 %$57M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,02 %$93M
    • Invesco QQQ TrustFunds · as of 2026-03-310,01 %$80M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,01 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,01 %$64M
    • Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,01 %$14M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,01 %$325M
    • EATON VANCE MANAGEMENTInstitutional Investor · as of 2022-09-300,01 %$0M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,01 %$9M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,01 %$45M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$31M
    • Wellington Management Company, LLPInvestment Managers · as of 2026-03-310,00 %$25M
    • T. Rowe Price Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$62M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$12M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$179M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$38M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$8M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$14M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$49M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$7M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$4M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$6M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$2M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$1M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$2M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$2M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$6M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M

    Insider activity

    Net buying2 buys · 0 sellsnet $1,2M13 insiders · last 365d
    • Huntsman Peter RDirector, Chairman, President & CEO · Common StockBought 100 000 @ $9,81$981K · 2026-08-03
    • Buberl JanDivision President · Common StockOther 422 @ $9,76$4K · 2026-07-31
    • Hansen Steen WeienDivision President · Common StockOther 883 @ $14,99$13K · 2026-06-02
    • Lister Philip M.Exec VP & CFO · Common StockOther 3 706 @ $13,21$49K · 2026-02-13
    • Rogers Robert WadeSr. VP, Human Resources · Common StockOther 1 417 @ $13,21$19K · 2026-02-13
    • Benko BrittanySr. VP, EHS · Common StockOther 630 @ $13,21$8K · 2026-02-13
    • Benko BrittanySr. VP, EHS · Common StockOther 909 @ $13,21$12K · 2026-02-13
    • Benko BrittanySr. VP, EHS · Common StockOther 1 281 @ $13,21$17K · 2026-02-13
    • Jorgensen Steven C.VP & Controller · Common StockOther 321 @ $13,21$4K · 2026-02-13
    • Jorgensen Steven C.VP & Controller · Common StockOther 414 @ $13,21$5K · 2026-02-13
    • Jorgensen Steven C.VP & Controller · Common StockOther 583 @ $13,21$8K · 2026-02-13
    • Huntsman Peter RDirector, Chairman, President & CEO · Common StockOther 16 804 @ $13,21$222K · 2026-02-13
    • Huntsman Peter RDirector, Chairman, President & CEO · Common StockOther 21 662 @ $13,21$286K · 2026-02-13
    • Huntsman Peter RDirector, Chairman, President & CEO · Common StockOther 19 184 @ $13,21$253K · 2026-02-13
    • Rogers Robert WadeSr. VP, Human Resources · Common StockOther 2 329 @ $13,21$31K · 2026-02-13
    • Hansen Steen WeienDivision President · Common StockOther 1 513 · 2026-02-13
    • Hansen Steen WeienDivision President · Common StockOther 449 @ $13,21$6K · 2026-02-13
    • Hansen Steen WeienDivision President · Common StockOther 1 950 · 2026-02-13
    • Hansen Steen WeienDivision President · Common StockOther 579 @ $13,21$8K · 2026-02-13
    • Hansen Steen WeienDivision President · Common StockOther 3 141 · 2026-02-13
    • Hansen Steen WeienDivision President · Common StockOther 932 @ $13,21$12K · 2026-02-13
    • Rogers Robert WadeSr. VP, Human Resources · Common StockOther 1 109 @ $13,21$15K · 2026-02-13
    • Buberl JanDivision President · Common StockOther 321 @ $13,21$4K · 2026-02-13
    • Buberl JanDivision President · Common StockOther 414 @ $13,21$5K · 2026-02-13
    • Buberl JanDivision President · Common StockOther 1 514 @ $13,21$20K · 2026-02-13

    Short positioning

    17.3Mshares short-3.2% vs prior
    3.93days to cover
    48.8%short of daily vol
    14.0Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    HUNCanonical
    NYSE · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    HUNBAS.DEDiversified Ch
    This companySectorPartners

    Evidence & claims

    From filings & derived data
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 26.2%Derived (calculated)
    • Net margin (FY 2025-12-31): -5.0%Derived (calculated)
    • Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): -4.6%Derived (calculated)
    • Current ratio (FY 2025-12-31): 1.30xDerived (calculated)
    • Return on assets (FY 2025-12-31): -4.0%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -50.0%Derived (calculated)
    • Return on equity (FY 2025-12-31): -10.3%Derived (calculated)
    • Gross margin (FY 2025-12-31): 13.2%Derived (calculated)
    • Debt-to-equity (FY 2025-12-31): 1.48xDerived (calculated)
    • Capex (YoY) (2025-12-31 vs 2024-12-31): -6.0%Derived (calculated)
    • Gross profit (YoY) (2025-12-31 vs 2024-12-31): -13.3%Derived (calculated)
    • Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 9.6%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): -50.3%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -50.0%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 2.7%Derived (calculated)
    • R&D expense (YoY) (2025-12-31 vs 2024-12-31): -0.8%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 9.9%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): -424.0%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): -5.8%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -7.1%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): -1.4%Derived (calculated)
    • Operating cash flow (annual): USD 289MSEC XBRL filing
    • Capex (annual): USD 173MSEC XBRL filing
    • Shareholders' equity (annual): USD 2.75BSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-08-03INSIDERHuntsman Peter R bought 100.0k sh — Director, Chairman, President & CEO ~$981k
    2026-07-31INSIDERBuberl Jan transacted 422 sh — Division President ~$4k
    2026-07-30 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-07-30EVENTQ2 2026 earnings (expected) estimated date
    2026-06-16FILINGFORM 8-K →
    2026-06-16FILINGFORM 8-K →
    2026-06-02 00:00 UTCINSIDER1 insider transaction — 2026-06
    2026-06-02INSIDERHansen Steen Weien transacted 883 sh — Division President ~$13k
    2026-05-01 16:13 UTCFILINGRegulatory filing →
    2026-05-01FILINGFORM 8-K →
    2026-05-01FILINGFORM 10-Q →
    2026-04-30FILINGFORM 8-K →
    2026-03-31EARNINGSQuarterly results — Q4 2025 Revenue USD 1.42B · Net USD -53.0M
    2026-03-16FILINGFORM DEF 14A →
    2026-02-18FILINGFORM 10-K →
    2026-02-17FILINGFORM 8-K →
    2026-02-13 00:00 UTCINSIDER50 insider transactions — 2026-02 · net buy $1.0M 9 derivative
    2026-02-13FILINGFORM 8-K →
    2026-02-13INSIDERLister Philip M. transacted 3.7k sh — Exec VP & CFO ~$49k
    2026-02-13INSIDERRogers Robert Wade transacted 1.4k sh — Sr. VP, Human Resources ~$19k
    2026-02-13INSIDERBenko Brittany transacted 630 sh — Sr. VP, EHS ~$8k
    2026-02-13INSIDERBenko Brittany transacted 909 sh — Sr. VP, EHS ~$12k
    2026-02-13INSIDERBenko Brittany transacted 1.3k sh — Sr. VP, EHS ~$17k
    2026-02-13INSIDERJorgensen Steven C. transacted 321 sh — VP & Controller ~$4k
    2026-02-13INSIDERJorgensen Steven C. transacted 414 sh — VP & Controller ~$5k
    2026-02-13INSIDERJorgensen Steven C. transacted 583 sh — VP & Controller ~$8k
    2026-02-13INSIDERHuntsman Peter R transacted 16.8k sh — Director, Chairman, President & CEO ~$222k
    2026-02-13INSIDERHuntsman Peter R transacted 21.7k sh — Director, Chairman, President & CEO ~$286k
    2026-02-13INSIDERHuntsman Peter R transacted 19.2k sh — Director, Chairman, President & CEO ~$253k
    2026-02-13INSIDERRogers Robert Wade transacted 2.3k sh — Sr. VP, Human Resources ~$31k
    2026-02-13INSIDERHansen Steen Weien transacted 1.5k sh — Division President
    2026-02-13INSIDERHansen Steen Weien transacted 449 sh — Division President ~$6k
    2026-02-13INSIDERHansen Steen Weien transacted 1.9k sh — Division President
    2026-02-13INSIDERHansen Steen Weien transacted 579 sh — Division President ~$8k
    2026-02-13INSIDERHansen Steen Weien transacted 3.1k sh — Division President
    2026-02-13INSIDERHansen Steen Weien transacted 932 sh — Division President ~$12k
    2026-02-13INSIDERRogers Robert Wade transacted 1.1k sh — Sr. VP, Human Resources ~$15k
    2026-02-13INSIDERBuberl Jan transacted 321 sh — Division President ~$4k
    2026-02-13INSIDERBuberl Jan transacted 414 sh — Division President ~$5k
    Showing the 40 most recent of 64 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage